(Q36429733)

14 August 2017

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (English)

1 reference

14 August 2017

0 references

Takashi Iizuka

1

1 reference

14 August 2017

Kotaro Iemitsu

2

1 reference

14 August 2017

Masahiro Takihata

3

1 reference

14 August 2017

Masahiko Takai

4

1 reference

14 August 2017

Shigeru Nakajima

5

1 reference

14 August 2017

Nobuaki Minami

6

1 reference

14 August 2017

Shinichi Umezawa

7

1 reference

14 August 2017

Akira Kanamori

8

1 reference

14 August 2017

Hiroshi Takeda

9

1 reference

14 August 2017

Takehiro Kawata

10

1 reference

14 August 2017

Shogo Ito

11

1 reference

14 August 2017

Taisuke Kikuchi

12

1 reference

14 August 2017

Hikaru Amemiya

13

1 reference

14 August 2017

Mizuki Kaneshiro

14

1 reference

14 August 2017

Atsuko Mokubo

15

1 reference

14 August 2017

Tetsuo Takuma

16

1 reference

14 August 2017

Hideo Machimura

17

1 reference

14 August 2017

Keiji Tanaka

18

1 reference

14 August 2017

Taro Asakura

19

1 reference

14 August 2017

Akira Kubota

20

1 reference

14 August 2017

Sachio Aoyagi

21

1 reference

14 August 2017

Kazuhiko Hoshino

22

1 reference

14 August 2017

Masashi Ishikawa

23

1 reference

14 August 2017

Yoko Matsuzawa

24

1 reference

14 August 2017

Mitsuo Obana

25

1 reference

14 August 2017

Nobuo Sasai

26

1 reference

14 August 2017

Hideaki Kaneshige

27

1 reference

14 August 2017

Fuyuki Minagawa

28

1 reference

14 August 2017

Tatsuya Saito

29

1 reference

14 August 2017

Kazuaki Shinoda

30

1 reference

14 August 2017

Masaaki Miyakawa

31

1 reference

14 August 2017

Yasushi Tanaka

32

1 reference

14 August 2017

Yasuo Terauchi

33

1 reference

14 August 2017

Ikuro Matsuba

34

1 reference

14 August 2017

28 December 2015

1 reference

Journal of Clinical Medicine Research

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

116-125

1 reference

14 August 2017

2

1 reference

Adiponectin: Probe of the molecular paradigm associating diabetes and obesity

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

The importance of weight management in type 2 diabetes mellitus.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Effect of weight loss with lifestyle intervention on risk of diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

The impact of ethnicity on type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Diagnosis and Classification of Diabetes Mellitus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4701067

21 September 2018

Identifiers

DOI

10.14740/JOCMR2417W

1 reference

14 August 2017

1 reference

14 August 2017

1 reference